Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (1931)	11/2/2000 11:48:00 PM
From: greedsgd_2000	Respond to of 52153

It will effect election, and will effect biotech valuation. Should be some biotech dumping tomorrow a.m - however, maybe some good buying opportunities at some point. Very hard to tell how this will play out for biotechs over the next 6 months should Gore get elected. He may just continue Clinton policies as it concerns relations with drug companies, prescription drugs, and even possible price controls. Gore may not get what he wants on drug legislation, as his election may not be viewed in mandate terms. Perhaps something can be worked out to keep biotech innovation going. However, had Bush been elected next Tuesday, I believed that would have been very positive for biotechs near term at least. At this point based upon what I am hearing tonight from different sources, Bush appears that he will not be elected.

To: scaram(o)uche who wrote (1931)	11/2/2000 11:56:01 PM
From: Larry Liebman	Respond to of 52153

Article in S.F. Chronicle (10.2.00) notes decrease in VC funding for dot-com's. Continues with, "As investors shifted their investment focus, health care companies enjoyed a record quarter, raising $1.6 billion in 126 deals. Biopharmaceuticals companies raised a record $663.6 million, almost 25 percent more than the second quarter". Which leads me to wonder, how investors may shift their focus to biotechs. At what point will managers of growth funds make serious commitments to biotech. FWIW, I heard that mutual funds cash positions are at the highest levels since 11.98.